Company intelligence / Profile preview

Germapharm

Moosburg an der Isar, Bavaria, Germany
Ownership
Private
Employees
~50
Development stage
Other
01

Overview

Germapharm GmbH is a specialized German pharmaceutical company and a core subsidiary of the Aristo Pharma Group, focusing on the hygiene and infection prevention sectors. Based in Moosburg, the company is a leading manufacturer of medical-grade disinfectants, antiseptics, and specialized hygiene products for clinical and retail markets. Germapharm operates as a key production hub within the Aristo network, utilizing advanced facilities for the manufacture of liquid and semi-solid pharmaceutical forms. In addition to its own product portfolio, the company provides comprehensive contract manufacturing (CMO) services, including formulation development and aseptic filling. Germapharm is ultimately owned by the Strüngmann family, prominent investors in the global biotechnology industry, and plays a critical role in the European healthcare supply chain.

Therapeutic areas
Infectious Diseases
Modalities
Small molecule
Industry
Biotech

Beyond the preview

Go deeper on Germapharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Germapharm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call